Alternatives to BioSymetrics

Developing digital therapeutics for various medical conditions.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for antibody discovery and development to create new medicines.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

AI-powered platform accelerating biological research and drug discovery.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

A global oncology company developing and commercializing innovative cancer treatments.

Simaya AI provides biologically-driven patient drug predictions for pharma and biotech, enhancing clinical trial success with individual response, toxicity, and dosage insights.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Computational oncology service analyzing tumor RNA-seq for origin, subtype, druggable alterations, and immune profile.

Developing engineered biologics to harness the immune system for disease treatment.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Advance every cancer decision.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Mining biological information for transformative peptide medicines.

Gene therapy company developing transformative treatments for severe genetic diseases.

Digital pathology imaging technology and AI-driven precision pathology software.

BioGene Therapeutics is a life sciences company developing novel gene therapy solutions for metabolic disorders like diabetes and obesity.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Develops a computational model of the human body for drug discovery and development.

Personalized computational drug screening for rare diseases using patient genetics and automation.

Global marketplace connecting researchers with human biospecimens for life science research.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered spatial biology platform for precision medicine and drug development.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotech company focused on designing and developing novel biological solutions.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.